Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Barclays cut the price target for Prologis, Inc. (NYSE: PLD) from $153 to $141. Barclays analyst Anthony Powell maintained an Overweight rating. Prologis shares fell 1.6% to close at $125.14 on Tuesday. See how other analysts view this stock.
- Truist Securities slashed the price target for Berry Global Group, Inc. (NYSE: BERY) from $75 to $68. Truist Securities analyst Michael Roxland downgraded the stock from Buy to Hold. Berry Global shares fell 0.4% to close at $59.23 on Tuesday. See how other analysts view this stock.
- Wedbush increased Netflix, Inc. (NASDAQ: NFLX) price target from $615 to $725. Wedbush analyst Michael Pachter maintained an Outperform rating. Netflix shares rose 0.3% to close at $629.24 on Tuesday. See how other analysts view this stock.
- Keefe, Bruyette & Woods boosted the price target for Wells Fargo & Company (NYSE: WFC) from $56 to $62. Keefe, Bruyette & Woods analyst David Konrad downgraded the stock from Outperform to Market Perform. Wells Fargo shares fell 0.1% to close at $56.68 on Tuesday. See how other analysts view this stock.
- JP Morgan raised KB Home (NYSE: KBH) price target from $68.5 to $70.5. JP Morgan analyst Michael Rehaut maintained a Neutral rating. KB Home shares fell 0.3% to close at $68.18 on Tuesday. See how other analysts view this stock.
- Keybanc boosted the price target for Intuit Inc. (NASDAQ: INTU) from $700 to $720. Keybanc analyst Alex Markgraff maintained an Overweight rating. Intuit shares gained 0.2% to close at $640.05 on Tuesday. See how other analysts view this stock.
- Tigress Financial increased Target Corporation (NYSE: TGT) price target from $180 to $210. Tigress Financial analyst Ivan Feinseth maintained a Buy rating. Target shares slipped 0.01% to close at $172.64 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. boosted Delcath Systems, Inc. (NASDAQ: DCTH) price target from $18 to $20. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating. Delcath Systems shares fell 1.1% to close at $4.61 on Tuesday. See how other analysts view this stock.
- Jefferies raised Nuvation Bio Inc. (NYSE: NUVB) price target from $1.4 to $10. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Nuvation Bio shares rose 28% to close at $2.88 on Tuesday. See how other analysts view this stock.
- Canaccord Genuity cut Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) price target from $21 to $9. Canaccord Genuity analyst Edward Nash maintained a Buy rating. Rani Therapeutics shares fell 1.7% to close at $3.18 on Tuesday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Check This Out: Carnival, GameStop And 3 Stocks To Watch Heading Into Wednesday
Latest Ratings for NFLX
| Mar 2022 | Wedbush | Upgrades | Underperform | Neutral |
| Jan 2022 | Citigroup | Upgrades | Neutral | Buy |
| Jan 2022 | Rosenblatt | Maintains | Neutral |
View the Latest Analyst Ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.